Fyr Bio
1 known investors
FYR develops an AI-enabled multi-omic platform (EV-Omics/EVO) that profiles extracellular vesicles in blood to decode RNA and protein signals for disease detection and characterization. Using its proprietary SPARCs enrichment technology, it supports diagnostics developers, drug developers, and precision medicine programs from biomarker discovery through clinical validation.